EVALUASI PENGGUNAAN OBAT ANTI HIPERTENSI TERHADAP PASIEN DI KLINIK TELAGA MEDIKA GUBUG

Kadamsih Kadamsih; Endang Setyowati; Ulviani Yulia Husna

doi:10.59003/nhj.v5i3.1628

Authors

Kadamsih Kadamsih Universitas Muhammadiyah Kudus
Endang Setyowati Universitas Muhammadiyah Kudus
Ulviani Yulia Husna Universitas Muhammadiyah Kudus

DOI:

https://doi.org/10.59003/nhj.v5i3.1628

Keywords:

Use Pattern, Evaluation, Antihypertensive, Hypertension

Abstract

Hypertension is a condition of blood pressure that is higher than normal, which can damage vital organs such as the heart, blood vessels, and kidneys. If left untreated, this condition increases the risk of heart attack, stroke, kidney failure, and death. The effectiveness of antihypertensive drugs is determined by their ability to lower blood pressure, generally 7–13 mmHg systole and 4–8 mmHg diastole to achieve blood pressure targets. This study aims to determine the rationality of anti-hypertension which is assessed in terms of the right dosage, indications, patients, and drugs at Telaga Medika Gubug Clinic. This study is a type of observational research (non-experimental) with a descriptive research design using the retrospective cohort method. The approach was carried out retrospectively with a research time of June 1, 2025 The research location was carried out at the Telaga Medika Gubug Clinic, with a total sampling of 155 respondents according to the inclusion and exclusion criteria. For data analysis using frequency distribution. Based on the results of the research on the characteristics of hypertension patients at Telaga Medika Gubug Clinic, the majority age frequency was 51-60 years, namely 81 respondents (52.3%), the gender of the respondent was mostly female, 110 respondents (71.0%), the education of the majority of respondents was high school, namely 54 respondents (34.8%) and the majority of respondents were farmers, 60 respondents (38.7%), the pattern of use of amlodipin as the most antihypertensive drugs (46.36%) and metformin as the most comorbidities (45.97%). All patients are right, namely the right indication, the right patient, and the right dose, but the accuracy of the drug is only 76.8%. The use of antihypertensive drugs at Telaga Medika Gubug Clinic was declared rational, for the accuracy of indications, patients, and dosages while for the accuracy of drugs was only 76.8%.

Downloads

Download data is not yet available.

References

Andriyani, R., & Fortuna, T. A. (2023). Evaluasi Penggunaan Obat Antihipertensi Dan Keberhasilan Terapi Antihipertensi Pada Pasien Hipertensi Dengan Diabetes Mellitus di Instalasi Rawat Jalan RSUD Dr. Moewardi Tahun 2021. Usadha Journal of Pharmacy, 341–360.

Antasya, E. R. (2023). Analisis Rasionalitas Obat Antihipertensi Pada Pasien Dewasa Hipertensi Yang Menjalani Rawat Inap Di Bangsal Rsud Dr Moewardi Surakarta. Universitas Kusuma Husada Surakarta.

Andriyani, R., & Fortuna, T. A. (2023). Evaluasi Penggunaan Obat Antihipertensi Dan Keberhasilan Terapi Antihipertensi Pada Pasien Hipertensi Dengan Diabetes Mellitus di Instalasi Rawat Jalan RSUD Dr. Moewardi Tahun 2021. Usadha Journal of Pharmacy, 341–360.

Aripin, Z. Z., Hikmah, S. N., & Rahmawati, R. A. (2024). Pola Penggunaan Obat Antihipertensi Terhadap Pasien Rawat Jalan Di UPTD Puskesmas Palimanan Cirebon Tahun 2022. Cendekia Journal of Pharmacy, 8 (1), 10–16.

Association, A. D. (2021). 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2021. Diabetes Care, 44 (Supplement_1), S7–S14.

Firdausia, F., Tyashapsari, T., Aripin, Z. Z. (2020). Pola penggunaan obat antihipertensi terhadap populasi pasien hipertensi di Puskesmas Palimanan tahun 2020. Cendekia Journal of Pharmacy, 1 (2), 122–128.

Herawati, N., Saputri, G. A. R., & Yasir, A. S. (2021). Evaluasi Rasionalitas Penggunaan Antihipertensi pada Pasien Geriatri di RSUD Dr. H Bob Bazar, SKM Lampung Selatan Rationality Evaluation of The Use of Antihypertensive in Geriatric Patient in Dr. H. Bob Bazar, SKM Public Hospital South Lampung. Journal of Islamic Medicine, 5 (2).

Indonesia, P. D. P. (2020). Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI), Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI), Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN), Ikatan Dokter Anak Indonesia (IDAI). Pedoman Tatalaksana COVID-19 Edisi, 2, 1–101.

Jones, K. E., Hayden, S. L., Meyer, H. R., Sandoz, J. L., Arata, W. H., Dufrene, K., Ballaera, C., Lopez Torres, Y., Griffin, P., & Kaye, A. M. (2024). The evolving role of calcium channel blockers in hypertension management: pharmacological and clinical considerations. Current Issues in Molecular Biology, 46 (7), 6315–6327.

Juwita, D. A., & Almahdy, W. Y. M. (2019). Perbandingan Efektivitas Penggunaan Kombinasi 2 Obat Antihipertensi Pada Pasien Hipertensi di Poliklinik Penyakit Dalam RSUP Dr. M. Djamil Padang.

Kemenkes RI. (2018). MANAJEMEN PROGRAM PENCEGAHAN DAN PENGENDALIAN HIPERTENSI Dan PERHITUNGAN PENCAPAIAN SPM HIPERTENSI.

Kemenkes RI. (2021). Laporan Kinerja Kementerian Kesehatan 2021. Kementrian Kesehatan RI.

Khuzaima, L. L. (2021). Hubungan Tingkat Pendidikan Terhadap Kepatuhan Minum Obat Antihipertensi Di Puskesmas Sewon Ii Periode Januari 2021. Jurnal Kefarmasian Akfarindo, 15–21.

Lolo, W. A., Citraningtyas, G., & Jayanto, I. (2024). Pola Penggunaan Obat Antihipertensi pada Pasien Rawat Jalan di Rumah Sakit X Manado. Medical Scope Journal, 6 (1), 142–148.

Purwono, J., Sari, R., Ratnasari, A., & Budianto, A. (2020). Pola Konsumsi Garam Dengan Kejadian Hipertensi Pada Lansia. Jurnal Wacana Kesehatan, 5 (1), 531.

Putri, L. S. A., Satriyasa, B. K., & Jawi, I. M. (2019). Gambaran pola penggunaan obat antihipertensi pada pasien hipertensi di Instalasi Rawat Inap RSUP Sanglah Denpasar tahun 2016. Jurnal Medika Udayana, 8 (6), 1–8.

Resmi, S. P. O. (2018). Evaluasi Rasionalitas Penggunaan Obat Antihipertensi pada Pasien Hipertensi di Instalasi Rawat Inap Rsud Ir. Soekarno Kabupaten Sukoharjo Tahun 2016. Skripsi. Surakarta: Fakultas Farmasi Universitas Setia Budi.

Sa’idah, D. (2018). Evaluasi Rasionalitas Penggunaan Obat Antihipertensi Di Instalasi Rawat Jalan RSUD Dr. Soegiri Lamongan Periode Tahun 2017. Malang: Universitas Islam Negeri Maulana Malik Ibrahim.

Sahputri, S. E. B., Irawati, A. D., & Azzahra, T. D. (2023). Evaluasi Efektivitas Antihipertensi Pada Pasien Rawat Inap Hipertensi Dengan Diabetes Melitus Di Rsu Dharma Husada. Jurnal Keperawatan, 16 (2), 23–31.

Spruill, T. M., Butler, M. J., Thomas, S. J., Tajeu, G. S., Kalinowski, J., Castaneda, S. F., Langford, A. T., Abdalla, M., Blackshear, C., & Allison, M. (2019). Association Between High Perceived Stress Over Time And Incident Hypertension In Black Adults: Findings From The Jackson Heart Study. Journal of the American Heart Association, 8 (21), e012139.

Tika, T. T. (2021). Pengaruh Pemberian Daun Salam (Syzygium polyanthum) Pada Penyakit Hipertensi: Jurnal Medika Hutama, 3, 1260–1265.

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C.,Wright, J. T. (2022). 2022 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology, 79 (14), e126–e248.

WHO. (2021). WHO model list of essential medicines-22nd list. World Health Organization Geneva.

WHO. (2023). Global Report On Hypertension: The Race Against A Silent Killer. World Health Organization.

Widyastuti, W., Noviar, N., & Putra, M. (2022). Gambaran penggunaan obat antihipertensi di bangsal penyakit Dalam RSUD dr. Achmad Darwis. SITAWA: Jurnal Farmasi Sains Dan Obat Tradisional, 1 (2), 59–70.

Zhou, T., Shen, W., Lu, J., & Wang, D. (2021). Antihypertensive prescribing patterns and their association with comorbidities in Chinese patients: a real-world study. BMC Public Health, 21 (1).

Zhou, B., Carrillo-Larco, R. M., Danaei, G., Riley, L. M., Paciorek, C. J., Stevens, G. A., Gregg, E. W., Bennett, J. E., Solomon, B., & Singleton, R. K. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398 (10304), 957–980.